Journal
CANCER LETTERS
Volume 355, Issue 1, Pages 85-95Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.09.012
Keywords
MicroRNAs; MiR-152; Glioblastoma; Stem cells; KLF4
Categories
Funding
- Natural Science Foundation of China [81172197, 81171131, 81272564, 81272795, 81372484, 81372682]
- Natural Science Foundation of Liaoning Province in China [201102300]
- Liaoning Science and Technology Plan Projects [2011225020]
- Shenyang Science and Technology Plan Projects [F11-264-1-15, F12-277-1-05, F13-318-1-16, F13-318-1-19, F13-220-9-15]
Ask authors/readers for more resources
Glioblastoma (GBM) is the most common central nervous system tumor and the molecular mechanism driving its development is still largely unknown, limiting the treatment of this disease. In the present study, we explored the potential role of miR-152 in glioblastoma stem cells (GSCs) as well as the possible molecular mechanisms. Our results proved that miR-152 was down-regulated in human GSCs. Restoring the expression of miR-152 dramatically reduced the cell proliferation, cell migration and invasion as well as inducing apoptosis. Mechanistic investigations defined Krfippel-like factor 4 (KLF4) as a direct and functional downstream target of miR-152, which was involved in the miR-152-mediated tumor-suppressive effects in GSCs. Meanwhile, this process was coincided with the down-regulated LGALS3 that could be bound and promoted by KLF4, leading to attenuate the activation of MEK1/2 and P13K signal pathways. Moreover, the in vivo study showed that miR-152 over-expression and KLF4 knockdown produced the smallest tumor volume and the longest survival in nude mice. Taken together, these results elucidated the function of miR-152 in GSCs progression and suggested a promising application of it in glioma treatment. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available